Govoptes

HR 5343 · Ensuring Patient Access to Critical Breakthrough Products Act

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

Introduced
Sep 15, 2025
Latest action
Sep 17, 2025
Sponsor
Rep. Blake D. Moore [R-UT-1]
Policy area
Health
Cosponsors
47

Recent actions

  1. Sep 17, 2025 Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
  2. Sep 17, 2025 Committee Consideration and Mark-up Session Held
  3. Sep 15, 2025 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Sep 15, 2025 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Sep 15, 2025 Introduced in House
  6. Sep 15, 2025 Introduced in House

Votes

No recorded votes are available for this bill.

Related pages